Gossypol Acetate + FOLFIRI + Bev in mCRC With TP53-Mutant and LRPPRC Positive

Clinical trial NCT07337551 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07337551
Sponsor: Guiying Wang
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Patients With Metastatic Colorectal Cancer Who Were TP53-mutant and LRPPRC-positive and Had Previously Failed Prior First-line Treatment

Start date: 2026-02-01
Primary completion: 2028-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.